首页> 外文期刊>GMS Thoracic Surgical Science >Bronchioloalveol?res Karzinom (BAC): Ergebnisse der operativen Behandlung bei 34 Patienten
【24h】

Bronchioloalveol?res Karzinom (BAC): Ergebnisse der operativen Behandlung bei 34 Patienten

机译:支气管肺泡癌(BAC):34例患者的手术治疗结果

获取原文
       

摘要

Bronchioloalveolar carcinoma (BAC) is a relatively rare tumor and represents a specific entity of non small cell lung cancer (NSCLC) because of its epidemiology, histology, and prognosis. In our study we present the history of 34 patients (13 women and 21 men) who had been operated on between January 2001 and August 2005 in curative intention. According to the UICC classification 23 patients were in stage I, 3 in stage II, 5 in stage III, and 3 in stage IV. In patients with nodular BAC the upper and middle lobe were significantly more affected than the lower lobe. We performed 9 segment- or wedge resections, 23 lobectomies, 1 extended lobectomy, and 1 pneumonectomy. The four year survival rate was 70.3%, the recurrence free survival rate was 75.0%.
机译:支气管肺泡癌(BAC)是一种相对罕见的肿瘤,由于其流行病学,组织学和预后因素,代表了非小细胞肺癌(NSCLC)的特定实体。在我们的研究中,我们介绍了2001年1月至2005年8月因治愈目的手术的34例患者(13名女性和21名男性)的病史。根据UICC分类,23例患者处于I期,II期3例,III期5例,IV期3例。在结节性BAC患者中,上叶和中叶的影响明显大于下叶。我们进行了9个节段或楔形切除,23个肺叶切除,1个扩展肺叶切除和1个肺切除。四年生存率为70.3%,无复发生存率为75.0%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号